Latest Commercial Development News

Bellavista Resources reports promising initial bioleaching results from its Brumby Project, confirming recovery of key critical minerals and advancing plans for bulk sample testing.

Xstate Resources has commenced drilling operations at its Diona-1 well in Queensland, targeting promising gas reservoirs with a rapid path to market.

Lakes Blue Energy reports strong gas shows at its Wombat-5 well in Victoria’s Gippsland Basin, reinforcing hopes for a commercially viable gas development.

Buru Energy has secured environmental approval for its 2026 Rafael resource appraisal drilling campaign, a crucial step toward final investment and first cashflows by 2028.

Meteoric Resources has confirmed exceptional rare earth recoveries from continuous piloting at ANSTO, producing high-quality Mixed Rare Earth Carbonate and demonstrating effective waste handling. This milestone advances the Caldeira Project towards commercial development and offtake agreements.

Sunrise Energy Metals Limited has had its trading suspension lifted following a fresh update to the Mineral Resource Estimate for its Syerston Scandium Project, signaling renewed market activity.

Emperor Energy has initiated a farm-in process to fund the Judith-2 appraisal well, aiming to unlock substantial gas reserves offshore Victoria and address tightening East Coast gas supply.

Estrella Resources and its partner PT Raka Energi Mandiri have agreed to extend key project milestones for their Werumata limestone venture in Timor-Leste, reflecting internal delays but maintaining a positive outlook.

Neurizon Therapeutics reported a $16.6 million loss for FY2025 amid significant progress in its lead neurodegenerative therapy NUZ-001, including regulatory milestones and a global licensing deal. The company is poised to enter a pivotal ALS clinical trial pending FDA clearance.

Omega Oil and Gas confirms the commercial viability of its Canyon Sandstone reservoir in Queensland’s Taroom Trough, with SLB modelling indicating nearly 1 million barrels of oil equivalent per well and significant upside potential.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

Stockland Corporation Limited reported a striking 170% surge in statutory profit for FY25, underpinned by a diversified property portfolio and a strategic new partnership to develop data centres with EdgeConneX.